Rafael Holdings, Inc. (NYSE:RFL) Stock Short Interest Report for October

Rafael Holdings, Inc. (NYSE:RFL) was the target of a large decrease in short interest during the month of October. As of October 15th, there was short interest totaling 348,361 shares, a decrease of 55.9% from the September 30th total of 789,108 shares. Based on an average daily trading volume, of 127,973 shares, the short-interest ratio is currently 2.7 days. Currently, 1.0% of the shares of the company are sold short.

Institutional Investors Weigh In On Rafael

An institutional investor recently raised its stake in Rafael stock. Renaissance Technologies LLC increased its stake in shares of Rafael Holdings, Inc. (NYSE:RFL) by 59.1% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 89,138 shares of the company’s stock after buying an additional 33,111 shares during the quarter. Renaissance Technologies LLC owned about 0.17% of Rafael worth $111,000 at the end of the most recent reporting period. 11.30% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts have weighed in on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of Rafael in a report on Tuesday, August 25th. Wall Street Zen upgraded Rafael to a “hold” rating in a report on Saturday, July 25th. One investment analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, Rafael presently has an average rating of “Sell”.

Rafael Stock Performance

Shares of RFL stock traded down $0.03 on Friday, hitting $1.09. The company’s stock had a trading volume of 67,242 shares, compared to its average volume of 72,806. The stock’s 50 day moving average is $1.84 and its 200-day moving average is $1.69. Rafael has a fifty-two week low of $1.08 and a fifty-two week high of $3.96. The company has a market capitalization of $56.94 million, a PE ratio of -1.89 and a beta of 0.35.

Rafael (NYSE:RFL) last released its quarterly earnings results on Thursday, October 29th. The company reported ($0.18) EPS for the quarter. The business had revenue of $0.24 million for the quarter. Rafael had a negative return on equity of 39.52% and a negative net margin of 3,390.73%.

About Rafael

Rafael Holdings, Inc (NYSE:RFL) is a diversified holding company with interests in biotechnology and commercial real estate. Through its life sciences operations, the company has focused on developing potential treatments for cancer and other serious diseases, including therapies designed to target the metabolism of cancer cells.

Rafael’s biotechnology activities have been conducted primarily through Rafael Pharmaceuticals, which has researched investigational drug candidates such as devimistat (also known as CPI-613).